Skip to main content
NUWE
NASDAQ Industrial Applications And Services

Nuwellis Seeks Shareholder Approval for Extreme Dilution from Warrants and Future Reverse Split Authority

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$4.024
Mkt Cap
$42.216M
52W Low
$2.881
52W High
$908.25
52W Position info
40% above low
Off High info
100% below high
Rel. Volume info
6.7× avg
Market data snapshot near publication time

NUWE sits 40% above its 52-week low of $2.881 on elevated volume (6.7× avg).

Summary

Nuwellis is seeking shareholder approval for the potential issuance of shares from warrants, which could lead to extreme dilution, and for authority to implement another reverse stock split, highlighting severe ongoing financial and listing challenges.


Key Events · Corporate Governance and Compliance · NUWE

  • Shareholder Vote on Warrant Exercise

    Stockholders will vote on approving the issuance of up to 2,396,709 shares upon warrant exercise from a recent $6.0 million offering. This represents approximately 2600% potential dilution of current outstanding shares (post-split).

  • Future Reverse Stock Split Authority Sought

    The Board is seeking approval for discretionary authority to implement another reverse stock split (1-for-5 to 1-for-70) within 12 months to maintain Nasdaq listing, following a 1-for-35 reverse split effective today.

  • Potential Capital Infusion

    If the warrants are fully exercised, the company could receive an additional $18.3 million, which is crucial for operations given its 'going concern' status, but the exercise price of $10.50 is above the current market price.

  • Ongoing Nasdaq Compliance Concerns

    The request for further reverse split authority so soon after a major split indicates persistent challenges in meeting Nasdaq's minimum bid price requirements.


Analysis · NUWE · Industrial Applications And Services

Nuwellis, a company under a 'going concern' warning, is seeking critical shareholder approvals that highlight severe ongoing financial and listing challenges. The vote on warrant exercise, while potentially bringing in $18.3 million in future capital, carries an extreme potential dilution of approximately 2600% of current outstanding shares. Furthermore, the request for authority to implement another reverse stock split, immediately after a 1-for-35 split, underscores persistent issues in maintaining its Nasdaq listing and share price, signaling ongoing financial distress and a high likelihood of further value erosion for shareholders.

At the time of this filing, NUWE was trading at $4.02 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $42.2M. The 52-week trading range was $2.88 to $908.25. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUWE - Latest Insights

NUWE
Aug 03, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.58
Real-time Price: $1.66 info
Change: +$0.0792 (+5%) info
Market Cap: $593.8K info
NUWE
Aug 03, 2026, 7:27 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.65
Real-time Price: $1.66 info
Change: +$0.0092 (+0.56%) info
Market Cap: $593.8K info
NUWE
Jul 31, 2026, 8:42 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $1.66 info
Change: -$0.3108 (-16%) info
Market Cap: $593.8K info
NUWE
Jul 27, 2026, 8:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.99
Real-time Price: $1.66 info
Change: -$0.3308 (-17%) info
Market Cap: $593.8K info
NUWE
Jul 24, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.01
Real-time Price: $1.66 info
Change: -$0.3462 (-17%) info
Market Cap: $593.8K info